BridgeMD
New treatment option for Mid-portion Achilles Tendinopathy
Official title Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy
ClinicalTrials.gov ID: NCT06969859
What this study is testing
- What it's testing
- This is a multi-centre, randomised, double-blind, placebo-controlled trial with two parallel groups in a 1:1 allocation to study the efficacy of Pulsed Electromagnetic Field Therapy (PEMF) in patients with mid-portion Achilles tendinopathy. All participants will be randomly divided into two groups: an intervention group (active PEMF and standard rehabilitation exercise) and a control group (sham PEMF and standard rehabilitation exercise).
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (\>18 years of age)
- Clinical diagnosis of mid-Achilles tendinopathy
- VISA-A score of \<60
- Ultrasound evidence of Achilles tendinopathy (thickening \>7mm)
You likely can't join if
- Previous invasive treatment to the Achilles tendon (e.g. rupture repair, PRP injection etc)
- Contraindication to PEMF (e.g. pregnancy, pacemakers)
- Physical or psychological comorbidities impairing the ability to complete assessments (eg neurological deficits etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Shatin, New Territories, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shatin, New Territories, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.